President & CEO of @npcnow. Tackling today’s greatest #healthpolicy challenges with data-driven evidence. Pharmacist & former senior @HHSGov advisor.
Washington, DC
Joined March 2007
- Tweets331
- Following1.3K
- Followers2.5K
- Likes1.1K
John Michael O'Brien retweeted
Investors across a range of stages, investment sizes, and fund types frequently reported that the #IRA of 2022 is exacerbating challenges in bringing innovative new medicines to market, according to new research in @Health_Affairs at academic.oup.com/healthaffai… 🧵
This summer marked the 1st anniversary of my dad's death from esophageal cancer. I can’t put a price on the memories made in his final months, but I know they were made possible by the medical innovation and the hope it provides. Read more via @LinkedIn: linkedin.com/pulse/when-inno…
Our Rutgers-NPC Fellows dream big, deliver impactful policy-relevant research, and drive better health policy — Do you aspire to do the same?
@npcnow will recruit soon for our next Health Policy & Communications Fellow. Apps open on October 8. More at npcnow.org/about/health-poli…
John Michael O'Brien retweeted
💊 Significant racial and ethnic disparities exist in prescription drug utilization and spending in the U.S., according to a new study in #JAMAHealthForum from the @npcnow in partnership with the @UW.
Read the full analysis at jamanetwork.com/journals/jam…
Honored to see our research on this important topic in the pages of @Health_Affairs Forefront.
healthaffairs.org/content/fo…
Click here to receive @npcnow's latest health policy research and subscribe to our weekly newsletter: npcnow.org/subscribe-updates
Click here to receive @npcnow's latest health policy research and subscribe to our weekly newsletter: npcnow.org/subscribe-updates
Cell & gene therapies (#CGTs) can be life-changing for patients — but too many barriers & obstacles impact their journey through diagnosis, treatment, & recovery. Understanding these barriers is essential to overcoming them.
Learn more in our new report: npcnow.org/sites/default/fil…
ALT NPC's Cell and Gene Therapy: Patient and Caregiver Odyssey
Join me at the #NatAllForum on 11/19! @sarahkemond of @icer_review, @sgremminger of @ntlalliancehlth, @CF_Pearson of @PetersonCHealth, @nilaydshah1 of @Delta, & I will discuss "Unlocking Value: Building Trusted Tools to Assess High-Value Care."
nationalalliancehealth.swoog…
During my residency, @AllHealthPolicy opened my eyes to the importance of good evidence — so I’m excited to participate in their Post-Election Symposium today! Join me, @AdamColborn @amcporg, @raenuzum @commonwealthfnd, & Dr. Marc Samuels @ADVIhealth: allhealthpolicy.org/events/p…
Honored to discuss #healthpolicy, #policyanalysis, & the amazing opportunities a PharmD creates w/ students @RutgersU Ernest Mario School of Pharmacy. We discussed the unintended consequences of the #IRA's #DPNP & #PBM reform — illustrated by current events & @npcnow's research.
Just @Allegiant instead of @AmericanAir from SRQ for the first time and wow, what a great decision. Plenty of space in their Extra seats, friendly crew, back in DC two hours before AA departs (IF on time), and I don’t have to deal with AA’s disinterested & unhappy gate agents.
I recently joined @gregwdaniel @EliLillyandCo, @ihdezdelso @UCSanDiego, & Dr. Sean Sullivan @UW_Pharmacy for an @ISPORorg webinar on the #IRA — Medicare’s #MFPs for the first 10 negotiated drugs & anticipated cost savings.
View the recording here: ispor.org/education-training…
This week, @JacquelynMMcrae & I gave a fireside chat at my alma mater, @nsucopsspr, to speak w/ students in @NSUSNPhA, the Legislative Task Force, & @kpsi. We loved sharing our personal experiences & advice for working & taking action in #healthpolicy. Go Sharks!
I'm looking forward to speaking at the #FierceBiotechSummit next week in Boston! Will you be there? Let me know — I'd love to connect!
Happy #LaborDay2024! As we celebrate workers today, I'm thrilled to share that @npcnow has been recognized as a Certified @GPTW_US. Thank you @Kim_Westrich for leading our efforts to create a culture that actively supports growth & drives excellence. greatplacetowork.com/certifi…
Our 2-year fellowship offers a world-class training experience for the next generation of pharmaceutical policy researchers & communicators. Learn more from current @RutgersU @npcnow Fellows at our networking session on 9/25 at 5:30PM ET!
Register here: pharmafellows.rutgers.edu/we…
We're looking for our 2025-2027 @RutgersU - NPC Health Policy & Communications Fellow! Be part of a best-in-class #healthpolicy #research organization & forge relationships w/ pharmaceutical industry leaders. Learn more below.
John Michael O'Brien retweeted
Check out this week's @cap_rx podcast ft. @drjmob and Dr. Julie Patterson! They're discussing their recent research on how prescription rebate guarantees & #PBMs are impacting employers & patients.
In our latest Astonishing Healthcare podcast episode, we enjoyed chatting with leadership at @npcnow about their recent survey of employers on pharma rebates, rebate guarantees, etc. + why pure administration solves many problems!
🎧 Listen when you can: cap-rx.com/insights/ah032---…
CMS told us the prices they’ve set for drugs millions use to stay healthy. We don’t yet know, in spite of what they said, what the impact for patients at the pharmacy counter will be.
Our research suggests the IRA will reduce the number of conditions new medicines are approved to treat and limit post-approval research used to establish treatment guidelines, while encouraging plans to limit access.
We’ll be watching what happens over the coming months and conducting new research about the impact of this law. Meantime, NPC's recent research on the IRA offers important insights. Access the studies here: bit.ly/4fOd0nk